Ljubica Matic is Assoc Prof of Molecular Medicine and Principal Researcher in the Vascular Surgery Division at Karolinska Institute (KI), Sweden. She obtained a MSc degree in Molecular Biology from Belgrade University, Serbia in 2003 and a PhD in Medical Biochemistry from KI in 2012. Since 2013 she is research coordinator for the Biobank of Karolinska Endarterectomy (BiKE, est 2002). In 2019 she became Group Leader for Translational Vascular Medicine at KI, dedicated to research on novel molecular targets for management of cardiovascular disease, i.e. atherosclerosis and restenosis complications. She is the recipient of grants and awards from the European Research Council, Swedish Research Council, Swedish Heart-Lung Foundation, Swedish Society for Medical Research, KI Faculty Consolidator programme, American Heart Association (Daniel Steinberg Early Career Investigator award 2023) and the Royal Swedish Academy of Sciences (Sven and Ebba Hagberg Award 2019).